Special Issue "Advances in Solid Lipid Micro- and Nanoparticle Technology"
A special issue of Pharmaceutics (ISSN 1999-4923).
Deadline for manuscript submissions: closed (31 December 2019).
Interests: controlled release; solid state properties; organic and inorganic nano- microparticles; inhaled dry powders; drug physical modification; cell microencapsulation and engineering
Special Issues and Collections in MDPI journals
Special Issue in Pharmaceutics: Methodology, Design and Regulatory Considerations for the Bioequivalence of Oral Inhaled Products
Special Issue in International Journal of Molecular Sciences: Advances in Nanostructured Materials between Pharmaceutics and Biomedicine 2.0
Special Issue in Pharmaceutics: Advances in Nanostructured Materials between Pharmaceutics and Biomedicine 2.0
Interests: drug delivery; pharmaceutical nanotechnology; nanomedicine; pulmonary drug delivery; cell encapsulation; tissue engineering
Undoubtedly, solid lipid micro- and nanoparticles show strong potential in a number of different therapeutic areas. Their proven safety and the availability of scalable manufacturing techniques rank solid lipid particles among the most attractive technologies. Unfortunately, the intrinsic solid state properties of lipids are detrimental to particle storage stability and sometimes restrict their market appeal. Therefore, in spite of the recorded progress, the solid lipid particle technology still strives to overcome unmet development issues.
This Special Issue aims to cover the most recent research efforts addressing lipid particle technology challenges. Special attention will be dedicated to manufacturing and novel cutting-edge technologies that may help to prevent the well-known issues of lipid materials and could foster the industrial development of these versatile delivery systems. Detailed topics are: advanced manufacturing techniques; new solid lipid particle engineering approaches to enhance stability and delivery performances; new approaches in the use of solid lipid particles for targeted or local drug delivery; technologies addressing delivery of biopharmaceutical products and hydrophilic compounds.
Prof. Stefano Giovagnoli
Prof. Paolo Blasi
Dr. Aurélie Schoubben
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Solid lipid nanoparticles
- Solid lipid microparticles
- Particle engineering
- Manufacturing methods
- Targeted delivery
- Local delivery
- Controlled release
- Biopharmaceutical products
- Solid state properties